Episode

Brant Peterson on Valo Health’s patient-first approach to drug discovery

Podcast
Data in Biotech
Published
Jan 29, 2026
Duration seconds
3153
Processing state
not_requested
Canonical source
https://www.corrdyn.com/
Audio
https://downloads.pod.co/5fac40cd-043b-485f-838d-c63fa01ae1b2/2a141b5e-13d7-4a87-b47d-b72a26acc7e0.mp3
JSON
/v1/public/podcasts/data-in-biotech-6628050/episodes/brant-peterson-on-valo-health-s-patient-first-approach-to-drug-discovery
Markdown
/podcast/data-in-biotech-6628050/brant-peterson-on-valo-health-s-patient-first-approach-to-drug-discovery.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/data-in-biotech-6628050/episodes/brant-peterson-on-valo-health-s-patient-first-approach-to-drug-discovery/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/data-in-biotech-6628050/brant-peterson-on-valo-health-s-patient-first-approach-to-drug-discovery.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Brant Peterson, Vice President & Fellow at Valo Health, joins Data in Biotech to explore how his team leverages real-world data, genetic insights, and machine learning to de-risk drug discovery. From building causal DAGs to identifying patient subtypes in neurodegenerative diseases like Parkinson’s, this episode dives deep into a patient-first, data-driven approach to biomedical innovation. What You'll Learn in This Episode: >> How Valo Health uses real-world evidence and EHR data to prioritize drug targets earlier in the development pipeline. >> Why integrating wet lab experiments and causal DAGs accelerates therapeutic validation. >> The importance of genetic pleiotropy and Mendelian randomization in refining disease hypotheses. >> How Valo Health identifies high-impact patient subgroups in neurodegenerative diseases like Parkinson’s and Alzheimer’s. >> Where machine learning models succeed and fall short, in uncovering mechanisms of disease from sparse longitudinal data. Meet Our Guest Brant Peterson is Vice President & Fellow in Data Science at Valo Health. He brings deep expertise in genetics, computational biology, and biomedical innovation. Formerly a Distinguished Data Scientist at Valo and Computational Biologist at Novartis, Brant focuses on leveraging patient-centric data to drive causal discovery in drug development. About The Host Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation. Connect with Our Guest: Sponsor: CorrDyn, a data consultancy Connect with Brant Peterson on LinkedIn Connect with Us: Follow the podcast for more insightful discussions on the latest in biotec…